Jupiter Life Line Hospitals Ltd

Jupiter Life Lin Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Jupiter Life Line Hospitals Ltd

₹ 1,496 -0.05%
03 Dec - close price
jupiterhospital.com BSE: 543980 NSE: JLHL
About

Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]

Key Points

Hospital Portfolio[1]
1. Locations and Bed Capacity
- Thane: Operational since 2007, 377 beds, average occupancy rate of 72.0%, and ARPOB (Average Revenue Per Occupied Bed) of ₹66,700.
- Pune: Operational since 2017, 375 beds, average occupancy rate of 67.0%, and ARPOB of ₹55,000.
- Indore: Operational since 2020, 231 beds, average occupancy rate of 59.0%, and ARPOB of ₹44,700.

New Developments[2]
- Added 22 beds in Pune in Q2 FY25.
- 75 additional beds are under development at the Indore hospital, expected by Q4 FY25.
- Construction of the Dombivli hospital is on track, and regulatory approvals are being finalized for a second unit in Pune. These expansions will raise the total bed capacity to ~2,500 beds.

Capex[3]
1) CWIP grew from 74 Crs in March 2024 to 135.1 Crs in September 2024, reflecting ongoing expansion projects.
2) The company spent 165.3 Crs on investments during H1 FY25.

Key Operating Metrics - H1FY25[4]
- Operational Beds: 851 beds.
- Occupancy Rate: 67.2%
- Patient Volume: Grew from 53,100 to 57,700.
- ALOS (Average Length of Stay): Slightly decreased to 3.85 days from 3.89 days.

Website BSE NSE
  • Market Cap ₹ 9,793 Cr.
  • Current Price ₹ 1,496
  • High / Low ₹ 1,654 / 1,037
  • Stock P/E 56.0
  • Book Value ₹ 203
  • Dividend Yield 0.07 %
  • ROCE 22.2 %
  • ROE 17.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 53.0% CAGR over last 5 years

Cons

  • Stock is trading at 7.38 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of Nifty Total Market Nifty Microcap 250 BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
179 198 200 210 208 227 230 245 239 273
130 141 154 158 157 168 173 189 184 204
Operating Profit 49 57 46 52 51 59 57 56 56 69
OPM % 27% 29% 23% 25% 25% 26% 25% 23% 23% 25%
2 2 2 4 5 5 8 11 8 9
Interest 7 7 7 7 8 9 1 1 1 1
Depreciation 7 7 7 7 8 8 8 7 8 10
Profit before tax 37 46 34 42 41 48 56 59 55 67
Tax % 0% 21% 79% 36% 25% 25% 25% 27% 26% 25%
37 36 7 27 30 36 42 43 41 50
EPS in Rs 7.31 7.10 1.28 4.73 5.39 5.51 6.44 6.58 6.20 7.67
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
320 398 463 461 657 787 911 988
266 333 380 392 498 583 687 750
Operating Profit 54 65 83 69 159 204 223 239
OPM % 17% 16% 18% 15% 24% 26% 25% 24%
5 2 2 4 4 11 30 36
Interest 16 24 26 28 29 28 19 4
Depreciation 20 24 26 27 28 29 31 34
Profit before tax 24 20 33 18 106 159 204 237
Tax % -25% 8% 10% 5% 20% 33% 25%
30 18 30 17 85 107 152 176
EPS in Rs 5.88 3.57 5.83 3.26 16.65 18.97 23.18 26.89
Dividend Payout % 8% 0% 0% 0% 0% 0% 4%
Compounded Sales Growth
10 Years: %
5 Years: 18%
3 Years: 25%
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: 53%
3 Years: 109%
TTM: 69%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 36%
Return on Equity
10 Years: %
5 Years: 19%
3 Years: 22%
Last Year: 18%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 51 51 51 51 51 57 66 66
Reserves 147 162 186 202 278 409 1,180 1,264
210 252 263 262 322 298 0 0
63 71 94 100 104 123 115 135
Total Liabilities 470 537 594 615 755 885 1,361 1,465
379 431 435 426 465 476 477 508
CWIP 28 12 10 13 14 16 61 116
Investments 1 2 2 65 71 95 111 177
63 92 146 109 205 297 711 664
Total Assets 470 537 594 615 755 885 1,361 1,465

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
43 46 75 113 142 184 110
-43 -58 -43 -78 -68 -130 -256
1 16 -32 -23 10 -23 311
Net Cash Flow 1 3 -1 12 84 31 164

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 20 24 35 16 15 19 19
Inventory Days 60 46 64 45 38 42 39
Days Payable 224 168 268 192 155 169 116
Cash Conversion Cycle -144 -98 -169 -132 -101 -108 -59
Working Capital Days 11 18 44 4 -4 -16 -7
ROCE % 10% 12% 9% 23% 27% 22%

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
40.91% 40.91% 40.91% 40.91% 40.91%
4.62% 3.96% 4.17% 6.06% 8.84%
12.69% 13.92% 14.16% 13.85% 13.46%
41.80% 41.19% 40.76% 39.18% 36.79%
No. of Shareholders 54,78239,34835,10735,79734,081

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls